Ritivixibat is an inhibitor of the ileal bile acid transporter (IBAT) and a bile acid modulator; it can be used in the research of cardiovascular diseases, disorders of fatty acid metabolism and glucose utilization, gastrointestinal diseases, and liver diseases.